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Summary
Cytoplasm at the posterior pole of the early Drosophila
embryo, known as polar plasm, serves as a source of
information necessary for germ cell determination and
for specification of the abdominal region. Likely candi-
dates for cytoplasmic elements important in one or both
of these processes are polar granules, organelles concen-
trated in the cortical cytoplasm of the posterior pole.
Females homozygous for any one of the maternal-effect
mutations, tudor, oskar, staufen, vasa, or valois give rise
to embryos that lack localized polar granules, fail to
form the germ cell lineage and have abdominal segment
deletions. Using antibodies against a polar granule
component, the vasa protein, we find that vasa synthesis
or localization is affected by these mutations. In vasa
mutants, synthesis of vasa protein is absent or severely
restricted. In oskar and staufen mutant females, vasa
synthesis appears normal, but the vasa protein is not
localized. In tudor and valois mutant females, vasa is
localized to the posterior pole of oocytes, but this
localization is lost following egg activation. In addition to
the posterior localized vasa, there is a low level of vasa
distributed throughout the embryo. A function for this
distributed vasa is postulated based on the observation
that embryos from Bicaudal-D mothers, in which ab-
dominal determinants are incorrectly localized to the
anterior pole, do not show any ectopic vasa localization,
though abdomen development at the anterior end
depends on the amount of vasa protein in the embryo.
Key words: vasa, polar granules, maternal-effect mutants,
cytoplasmic determinants.
Introduction
Asymmetric segregation of cytoplasmic components is
observed during early stages of embryogenesis of many
vertebrate and invertebrate embryos (Davidson, 1986).
One well-known example is the polar plasm of Dros-
ophila, which contains large numbers of organelles
called polar granules (Mahowald, 1962, 1968). Polar
granules are electron-dense, RNA-rich cytoplasmic or-
ganelles, and are concentrated to the posterior pole of
late stage oocytes and early embryos (Mahowald, 1968,
19716). Several lines of evidence indicate that these
structures are required for the localization and/or
function of posteriorly localized cytoplasmic determi-
nants required for the formation of the germ cell lineage
and for proper abdomen specification. First, mutations
of vasa, which codes for a component of polar granules,
abolish the formation of germ cells and alter abdominal
segment specification (Schiipbach and Wieschaus, 1986;
Hay etal. 1988a,6; Lasko and Ashburner, 1988). Sec-
ondly, six other maternal-effect mutations {tudor, Bos-
well and Mahowald, 1985; Schiipbach and Wieschaus,
1986; staufen, valois, Schiipbach and Wieschaus, 1986;
oskar, Lehmann and Niisslein-Volhard, 1986; and cap-
puccino and spire, Manseau and Schupbach, 1989),
which disrupt formation of the germ cell lineage and
abdomen specification, also produce embryos without
localized polar granules. Finally, the temporal distri-
bution of RNA-rich polar granules in wild-type oocytes
and embryos coincides with the ability of polar plasm to
induce germ cell determination (Mahowald, 1971i>;
Illmensee etal. 1976; Niki, 1986).
Synthesis of polar granule components and their
localization to the posterior embryonic pole occurs
during oogenesis. Assembly of the granule probably
occurs in the nurse cells, germline feeder cells, because
these cells contain large cytoplasmic masses (nuage)
which resemble polar granules, and which contain an
identified component of polar granules, the product of
the vasa locus (Hay et al. 1988a). During the second half
of oogenesis (stages 10-14 of King, 1970), the nurse
cells inject essentially all of their cytoplasmic contents
into the growing oocyte through intercellular bridges
located at the anterior pole of the oocyte. Cytoplasmic
mixing rapidly distributes this material throughout the
ooplasm (Gutzeit and Koppa, 1982). This is the period
during which localization of polar granules to the
posterior pole occurs (Mahowald, 1971a). This pos-
terior localization, in spite of entry at the anterior pole
and rapid mixing, probably involves specific transport
mechanisms which target polar granules to the posterior
pole. Maintenance of this posterior localization may in
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turn require specific interactions between receptors at
the posterior pole and certain polar granule com-
ponents.
To understand the requirements for polar granule
localization and to identify stages involved in this
process, one may follow the fate of known granule
components in mutants that lack localized polar gran-
ules. Here we report experiments in which we have
followed the fate of the vasa protein, a component of
polar granules, during oogenesis and embryogenesis in
a number of mutants. Implications of vasa function and
of mechanisms of granule localization will be discussed.
Materials and methods
Stocks
Drosophila melanogaster were raised on standard corn-
meal-yeast-agar medium at 25 °C. Normal flies were of
Oregon-R (OR) wildtype strain. Balanced stocks of vasa
(vasaPD23 and vasaDL), tudor (tudor™08), a deficiency that
uncovers the tudor locus (Df(2L)PL3), staufen, staufen LS4, a
deficiency that uncovers the staufen locus (Df(2L) PC4),
valois, (valoisRB) and a deficiency that uncovers the valois
locus (Df(2L)TW2), were provided by Trudi Schiipbach,
Princeton University, Princeton, NJ. Other stocks of tudor
{tudor2, tudor2, tudor4) were provided by Robert Boswell,
University of Colorado, Boulder, CO. Stocks of the two
deficiencies Df(2L)A267 and Df(2L)TE116-GW18, which in
heterozygous combination delete part of the vasa locus,
staufen (staufen03), oskar (oskar1'*, oskar236, oskar301), a
deficiency that uncovers the oskar locus, stocks of valois
(valoisPE) and stocks of Bicaudal-D (Bicaudal-D7134, Bi-
caudal-D ) were provided by Ruth Lehmann, Whitehead
Institute, Cambridge, MA.
Fly crosses
For most experiments, homozygous females were collected
from balanced stocks and mated with OR males. For the
creation of a deletion of a part of the vasa locus, virgin
Df(2L)A267/CyO females, which are deleted for a part of the
vasa locus, were crossed to Df(2L)TE116-GW18/CyO males,
which are also deleted for a part of the vasa locus, and non-
CyO progeny selected. The only transcription unit affected by
both deficiencies in these flies is vasa (Lasko and Ashburner,
1988).
Production of polyclonal anti-vasa rabbit serum
A trpE-vasa fusion protein was used as the immunogen. Site
directed mutagenesis was carried out to create an Ndel
restriction site at the initial methionine of a full-length vasa
cDNA cloned into bluescript SK- (Stratagene) as described
(Kunkel etal. 1987). A pair of oligonucleotides was syn-
thesized, phosphorylated and annealed using standard tech-
niques (Maniatis et al. 1982) such that BamHl and Ndel sites
were created as opposite ends of the oligonucleotide. A gel-
purified Ndel-Xbal fragment containing the entire vasa
coding region was mixed with these oligonucleotides and
ligated into the vector PATH1, cut with Bamlil and Xbal.
This vector contains the trpE coding sequence (Dieckmann
and Tzagaloff, 1985). Bacteria containing either a trpE-vasa
construct or trpE alone were grown and induced according to
Driever et al. (1988). Fusion protein was isolated according to
Rio et al. (1986), dissolved in sample buffer (Laemmli, 1970)
and subjected to preparative SDS-PAGE. Protein bands
were visualized by incubating the gel with 0.25 M KC1 in H2O.
The gel slice containing the trpE-vasa fusion protein was cut
out and chopped into small bits. These were then suspended
in complete Freund's adjuvant (incomplete for booster injec-
tions). Rabbits (Berkeley Antibody Company, Berkeley, CA)
were injected at multiple subcutaneous and intramuscular
sites, boosted after 4 weeks, and bled at biweekly intervals
thereafter. Two rabbits produced high titers against the vasa
protein. To purify antibodies specific for the vasa portion of
the fusion protein, the following procedure was carried out.
Bacterial extract from cells expressing either the trpE-vasa
protein or trpE alone were dialyzed into coupling buffer (0.1 M
Hepes (pH7.5), 10% glycerin, 5mM EDTA). Precipitated
material was sedimented at lOOOOg, lOmin. The supernatants
were used to prepare affinity columns (Affigel 10/15, 1:1
ratio; Biorad) according to the manufacturer's protocol.
Following coupling, these columns were washed exhaustively
with 0.5 M NaCl, 10M Tris-HCl, pH 7.5, and then with elution
buffer containing 0.2 M glycine, 0.15 M HC1, 0.5 % Tween-20,
pH3.5. The column was then equilibrated with antibody-
binding buffer (50mM Tris-HCl, pH7.5, 5ITIM EDTA). Rab-
bit serum was dialyzed into antibody-binding buffer and then
incubated overnight at 4°C batchwise with column material
containing bacterial extract induced to express trpE alone.
The unbound material was incubated batchwise for four hours
at room temperature with affigel containing extract from the
trpE-vasa expressing bacteria. This affigel was then poured
into a column and washed with 50 column volumes of
antibody-binding buffer. Bound protein was eluted with 3
column volumes of elution buffer. Elution volumes were
immediately neutralized with 1 M Tris base and brought to a
final concentration of 1% BSA, 0.02% sodium azide.
Jmmunocytochemistry
Antibody staining of different stages of oogenesis and em-
bryogenesis with monoclonal antibody Mab46Fll, which
recognizes the product of the vasa locus, was carried out as
described in Hay etal. (1988o). For immunocytochemistry
using the polyclonal antisera, tissue was incubated for lh at
room temperature with the affinity-purified anti-vasa anti-
bodies at a dilution of 1:1000 in antibody buffer (0.1 M sodium
phosphate, pH7.5, 0.3% Triton X-100, 0.3% sodium deoxy-
cholate, 2% bovine serum albumin (Miles, fraction V)).
Three, 15min washes in antibody-binding buffer were fol-
lowed by incubation of the tissue for 1 h at room temperature
with horseradish peroxidase-conjugated goat anti-rabbit IgG
(Biorad, EIA grade) at a dilution of 1:1000. Following three
15min washes as above, the diaminobenzidine reaction prod-
uct was developed as described in Hay etal. (1988a). DNA
was visualized by incubating embryos with 0.5j/gmr' 4',6
diamidine-2-phenylindole dihydrochloride (DAPI, Boehr-
inger Mannheim Biochemicals) in 0.1 M Tris-HCl for lOmin
at room temperature and then washing for lOmin in Tris
buffer alone. The embryos were then mounted in 80%
glycerol, 0.1M Tris-HCl, pH9.0, 5% (wt/vol) n-propyl
gallate.
Western blotting
For Western blotting, 1 h collections of embryos were dechor-
ionated in bleach: water (1:1), rinsed extensively with water
and staged under a dissecting microscope. Cleavage stage
embryos were then processed as described in Hay et al.
(1988a) for Western blotting using the monoclonal antibody
Mab46Fll.
Oocyte activation
Oocyte activation was carried out according to Mahowald
etal. (1983). Ovaries from well-fed virgin females were hand
dissected and activated by placing them in 50% Robb's
medium for up to several hours. Removal of unactivated
occytes and dechorionation was carried out by removing the
Robb's medium and adding a 30% solution of commercial
bleach for several minutes. The surviving activated oocytes
were then fixed as above for embryos and devitellinized by
hand. Antibody staining was as above.
Results
Embryos derived from females homozygous for strong
alleles of the five posterior group genes, vasa, staufen,
oskar, valois and tudor, all have abdominal deletions,
fail to form germ cells and lack polar granules at the
posterior embryo pole. To examine the effects of these
mutations on granule localization, we used monoclonal
and polyclonal antibodies against the vasa product, a
component of polar granules, and carried out Western
(immunoblot) analysis and immunocytochemical stain-
ing of oocytes and embryos derived from homozygous
mutant mothers. Null, as well as weaker alleles of vasa,
were first analyzed to verify the specificity of the
antibodies, before the studies of the other mutations. In
order to assess the severity of these mutations, we
compared the phenotypes generated by homozygous
mutant females with those arising from females carrying
the same mutation on one chromosome and a deletion
of the locus on the other chromosome.
vasa distribution in embryos and oocytes of the wild-
type and of vasa mutants
In wild-type embryos, vasa immunoreactivity, as seen
vasa localization in maternal-effect mutants ATI
with monoclonal antibody Mab46Fll, is concentrated
in the form of polar granules at the posterior pole (Hay
etal. 1988a,b). Lower levels of immunoreactivity are
also found throughout the embryo during cleavage
stages (Hay etal. 1988b). Because the vasa protein
appears to have many different cellular associations: as
a part of polar granules during oogenesis and early
embryogenesis, as a part of the nuage or dense bodies in
the adult germline, and distributed throughout the
somatic region of the preblastoderm embryo, we were
concerned that in some situations the epitope of vasa
recognized by monoclonal antibody Mab46Fll might
be masked, and thus we would be missing some
populations of vasa proteins in our immunocytochemi-
cal analysis. To avoid this potential difficulty in the
interpretation of our immunocytochemical data, we
immunized rabbits with a full-length vasa protein made
as a fusion with the bacterial protein trpE (see Materials
and methods) in order to generate polyclonal anti-vasa
antibodies. Vasa immunoreactivity, as seen with the
polyclonal antiserum, shows a similar pattern during
early embryogenesis (Fig. 1A). The immunoreactivity
seen with monoclonal or polyclonal antibodies, local-
ized to the posterior pole and present at lower levels
throughout the embryo, is absent in embryos from
homozygous vasaPD females (a hypomorphic allele)
(see Hay etal. 1988b, Fig. 4) (Fig. IB). Thus, both
antibodies appear specific for the vasa product during
early embryogenesis. The specificity of these antibodies
for the vasa product is further demonstrated by Western
analysis of proteins extracted from vasa cleavage stage




Fig. 1. Immunoreactivity in wild-type and
vasa mutant ovaries as visualized using
polyclonal rabbit anti-vasa antibodies.
Younger stages of oogenesis, and the anterior
of any given egg chamber are located to the
left. (A) Cleavage stage wild-type embryo.
Label is concentrated at the posterior embryo
pole. A general background level of staining is
present throughout the somatic regions of the
embryo. (B) vasaPD cleavage stage embryo.
No staining is present, at the posterior pole or
throughout the rest of the embryo. (C) Wild-
type ovary. (D) Homozygous vasa ovary.
Label is primarily present in the germarium
and early vitellarium stages (indicated by the
arrows). (E) A vasa null ovary, which does
not show any late stage oocytes. Label is
undetectable. (F) A vasa null ovary, which
does show a later stage oocyte (approximately
stage 10). Label is not present.
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Fig. 2. Western blot of cleavage stage embryos from wild-
type and homozygous mutant mothers for the mutations
vasa, tudor, oskar, staufen, and valois. A 72xlO3Mr band is
absent only in the vasa embryo lane. There is a lower
molecular weight band present in all lanes whose identity is
unknown. This band provides a convenient marker for
relative gel loading (see also Hay et al. 1988a). Protein from
cleavage stage embryos was prepared as in Hay et al.
(1988a) and 10/*g loaded per lane.
In ovaries of homozygous vasaPD females, vasa
immunoreactivity is restricted to early stages, primarily
the germarium, in which the geometry of the oocyte-
nurse cell complex is set up. Occasionally, low levels of
vasa immunoreactivity are also found in early stages of
the vitellarium, in which the bulk of oocyte and nurse
cell growth occurs (Fig. ID; compare with wild type in
Fig. 1C). In a female null for vasa function (see
experimental methods for details), oogenesis is usually
not completed. In ovaries of many such females, egg
chambers do not develop beyond the early stages of the
vitellarium (Fig. IE), whereas in other ovaries egg
chambers at later stages of oogenesis are present (up
through stage 14) (Fig. IF). None of these show any
vasa immunoreactivity with either the monoclonal or
polyclonal antibody. These observations show that our
anti-vasa antibodies recognize only the vasa protein
during oogenesis and early embryogenesis.
oskar and staufen mutations eliminate or reduce vasa
localization during oogenesis
The oskar and staufen mutations affect vasa localization
during oogenesis. Ovaries from strong (strength being
defined relative to the amount of abdominal segment
deletion seen) alleles of oskar and staufen, oskar36 and
staufen03 or these mutations in trans to deficiencies
uncovering the respective loci, show a normal pattern
of vasa expression in the nurse cells (Fig. 3A,B).
Immunoreactivity appears in the oocyte around stage
10, but never becomes localized to the posterior pole of
stage 14 oocytes (Fig. 3C,D). Localization is also not
seen in early cleavage stage embryos (Fig. 3E,F).
Western analysis reveals that normal levels of vasa
product are present in early embryos of oskar166 (and
oskar336, data not shown) or staufen03 mothers (Fig. 2).
This may derive from vasa synthesized by nurse cells
and transported into the oocyte, or it may come from
translation of vasa from the large amount of maternally
derived vasa RNA present in the early embryo (Hay
et al. 1988b). Although it remains possible that these
mutations affected the stability of just the population of
vasa that ends up at the posterior pole, from the fact
that the absolute levels of vasa are not affected in these
mutations, and in the absence of any information
suggesting the existence of populations of vasa that
differ in their stability, we favour the hypothesis that
these mutations directly affect vasa localization. This
phenotype is likely due to a reduction or loss of
function, because a similar pattern of expression is seen
immunocytochemically in oskar336 and staufen03 fe-
males which carry the mutation on one chromosome
and a deficiency for the region on the other chromo-
some.
A correlation between vasa localization and mutant
phenotype is evident in a temperature-sensitive oskar
mutant, osk301. At 18°C, the permissive temperature,
many embryos show normal abdominal segmentation
and hatch, though pole cells do not form. At 29°C, they
have strong abdominal deletions, in addition to the
absence of pole cells (Lehmann and Niisslein-Volhard,
1986). The degree of vasa localization in these embryos
is correlated with the severity of the abdominal defect.
At 18°C, some vasa is found localized to the posterior
pole of stage 10 oocytes, following oviposition weak
localized staining is sometimes seen in cleavage stage
embryos (Fig. 3G,H). Occasionally structures that re-
semble polar buds are formed, but these do not develop
into pole cells and by blastoderm formation localized
vasa immunoreactivity is undetectable. At the nonper-
missive temperature, oskar301 resembles oskar336 with
respect to its vasa localization phenotype (Fig. 3I,J).
valois and tudor mutations affect vasa localization
during embryogenesis
The valois and tudor mutations tested affect vasa
localization during early embryogenesis. Oocytes of
homozygous valoisRB71 or valoisPE, or valoisPE/
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Fig. 3. vasa localization in stages of oogenesis and early
embryos from homozygous oskar and staufen mothers. All
antibody stainings were carried out with polyclonal anti-
vasa antibodies. (A) Stage 10 oskar336 egg chamber. Label
is present in nurse cells and in the oocyte but is not
localized to the posterior oocyte pole. (B) Stage 10
staufen03 egg chamber. Label is present in nurse cells and
oocyte but not localized to the posterior oocyte pole.
(C) Cryostat section of an oskar336 stage 14 oocyte.
Posterior label is not present. (D) Cryostat section of a
staufen03 stage 14 oocyte. Posterior label is not present.
(E) oskar336 early cleavage stage embryo. Localized label is
not present. (F) staufen early cleavage stage embryo.
Localized label is not present. (G) Stage 10 oocyte from
oskar301 female raised at 18°C. Some localized label is
present at the posterior oocyte pole. (H) Early cleavage
stage embryo from oskar301 female raised at 18°C. A small
amount of label is localized to the posterior embryo pole.
(I) Stage 10 oocyte from oskar30^ female raised at 29°C.
Label is not detectably localized to the posterior oocyte
pole. (J) Early cleavage stage embryo from oskar301 female
raised at 29°C. Label is not detectably localized to the
embryo posterior pole.
Df(2L)TW2 females, have vasa localized to their pos-
terior pole at stage 10 through stage 14, as in the
wildtype (Fig. 4A,B). However, following oviposition
localized vasa immunoreactivity rapidly disappears,
such that by the time of cellular blastoderm formation
no localized immunoreactivity is present (Fig. 4C,D).
Wild-type amounts of vasa immunoreactivity are pres-
ent, however, by Western blotting (Fig. 2). When
mutant embryos are also stained with DAPI to visualize
their DNA, embryos with localized vasa show no more
than several cleavage nuclei, whereas embryos that
have proceeded through further cleavage divisions
show no signs of localized vasa. This indicates that vasa
localization is lost very rapidly following fertilization,
long before pole cell formation would have occurred.
Embryos from homozygous tudorwc& mothers have a
very variable segmentation defect, with some embryos
showing normal segmentation and others having ab-
dominal deletions of varying size (Schiipbach and
Wieschaus, 1986). Females carrying tudor-WC8 on one
chromosome and a deficiency for the region on the
other consistently give rise to embryos with a stronger
phenotype, indicating that tudor ^ (as with other
published tudor alleles) is probably a hypomorphic
allele (Schupbach and Wieschaus, 1986). In both the
homozygous mutant and hemizygous situation, normal
vasa localization and accumulation at the posterior pole
is observed during the second half of oogenesis
(Fig. 4E,F). Following oviposition, early cleavage stage
embryos still have localized vasa immunoreactivity
(Fig. 4G), whereas in later cleavage stage embryos, it
becomes progressively weaker (Fig. 4H). In some em-
bryos, pole cell buds are observed to form (Fig. 41), but
these buds disappear by blastoderm formation
(Fig. 4J,K). Localized vasa immunoreactivity is always
absent by blastoderm formation (Fig. 4K), as is the
general background seen during cleavage stages in wild-
type and mutant embryos.
tudorwcs embryos have some small electron-dense
structures associated with mitochondria. These struc-
tures may be some form of polar granule. In a pheno-
typically weaker allele, such as tudor2, more of these
structures can be found and a more normal abdomen
develops in the embryo (Boswell and Mahowald, 1985).
Correspondingly, in these embryos localized vasa im-
munoreactivity is more intense and frequent, though
this immunoreactivity still disappears prior to blasto-
derm formation.
vasa localization in Bicaudal-D embryos
In some of the embryos from mothers carrying the
dominant bicaudal mutation Bicaudal-D, anterior
structures are reduced or absent, and in extreme cases a
posterior abdomen is duplicated in mirror-image sym-
metry to the normal abdomen, at the anterior end
(Mohler and Wieschaus, 1986). At the transformed
anterior end polar granules are not apparent and pole
cells do not form, though in wild-type embryos a source
of abdomen-inducing activity is colocalized at the pos-
terior pole along with the germline determinants
(Frohnhofer et al. 1986; Lehmann and Niisslein-Vol-




M Fig. 4. vasa localization in stages of oogenesis and early
• ' embryogenesis from va/o«PE/Df(2L)TW2 and
tudor"-*/Dt(2R)PL3 mothers. All antibody stainings were
v carried out with polyclonal anti-vasa antibodies. Similar
/ observations were made with monoclonal antibody
Mab46Fll. (A) Stage 10 va/oisPE/Df(2L)TW2 oocyte.
Some label is localized to the oocyte posterior pole.
(B) Cryostat section of a stage 14 vo/oisPE/Df(2L)TW2
oocyte. A dense cortical band of label is present at the
oocyte posterior pole. (C) Early cleavage stage
va/owPE/Df(2L)TW2 embryo, which shows some label at
the posterior embryo pole. (D) Later cleavage stage
vo/owPE/Df(2L)TW2 embryo with no localized posterior
label. (E) Stage 10 rudorwC*/Df(2R)PL3 oocyte. Localized
label is present at the posterior oocyte pole. (F) Stage 14
tadorwd8/Df(2L)PL3 oocyte. A dense band of label is
present at the posterior oocyte pole. (G) Early cleavage
stage tudorwcA/Df(2R)PL3 embryo. Large amounts of label
v are localized to the embryo posterior pole. (H) Later
/ cleavage stage r«dorWC8/Df(2R)PL3 embryo. Label is
becoming more diffuse. (I) tadorWC8/Df(2R)PL3 embryo in
the process of forming pole buds. Some localized label is
present. (J) Slightly later stage mA?rWC8/Df(2R)PL3
embryo than in (I). The blastoderm is about to form. Pole
buds are not present. A very faint localized label is present
at the posterior embryo pole. (K) /udorWC8/Df(2R)PL3
* embryo beginning gastrulation. Pole cells are not present.
Localized posterior label and the general background
staining are absent.
K
hard, 1986). The maternally encoded product of the
nanos locus is likely to be the active component in the
abdomen-inducing activity (Sander and Lehmann,
1988; Hulskamp et al. 1989; Irish et al. 1989; Struhl,
1989). Genetic and cytoplasmic transplantation exper-
iments suggest that in Bicaudal-D, but not in wild-type
embryos, nanos activity is localized at the anterior pole
of the egg, as well as at the posterior pole (Lehmann
and Nusslein-Volhard, 1986; Wharton and Struhl,
1989). Interestingly, in Bicaudal-D females that are also
heterozygous for vasa, the bicaudal phenotype is sup-
pressed (Mohler and Wieschaus, 1986). The vasa-
dependent suppression of the bicaudal phenotype indi-
cates that vasa is required for the ectopic function of
nanos activity, vasa-dependent suppression may occur
during oogenesis or in the egg following fertilization.
One possibility is that vasa is required for ectopic
localization of the nanos product, for instance by
forming a complex with nanos which becomes localized
to the anterior end in a Bicaudal-D embryo. If this is
correct, vasa should be localized to the anterior pole as
well as to the posterior pole in Bicaudal-D embryos.
This hypothesis has not been borne out; under egg-
laying conditions in which Bicaudal-D females produce
large numbers of embryos with a bicaudal phenotype,
we see no localization of the vasa protein to the anterior
pole of oocytes, in vitro activated eggs or early cleavage
stage embryos. A failure to see vasa localization to the
anterior pole of Bicaudal-D embryos has been indepen-
dently noted by Wharton and Struhl (1989). Since vasa
distribution in a Bicaudal-D embryo is normal, it is not
the case that the formation of the anterior abdomen is
initiated via a mislocalization of vasa, and the bicaudal
egg must increase the concentration of posterior rescu-
ing activity {nanos product) at the anterior end inde-
pendent of vasa localization. Given that formation of
the anterior end still requires vasa activity, vasa must
have a function other than simply localizing nanos (see
discussion).
Discussion
Polar granules are concentrated at the posterior pole of
late stage oocytes and early embryos, and may be
involved in the posterior localization and function of
germ cell determinants and activities that specify ab-
dominal segmentation. We have shown previously that
the vasa protein is an essential component of the polar
granule (Hay et al. 1988a,b). In an attempt to study the
mechanism and function of polar granule localization,
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we have followed the fate of the vasa product in six
maternal effect mutants, vasa, staufen, oskar, valois,
tudor, and Bicaudal-D, because these mutations alter
localization of cytoplasmic determinants required for
development of the germ line and for embryonic
abdomen formation.
Functions of vasa
The phenotype of vasa is complex. A hypomorphic
allele, vasa , has vasa immunoreactivity restricted
largely to the germarium, and fails to localize (or
perhaps even assemble) polar granules. In contrast, null
mutants are usually blocked during early oogenesis at
roughly the stages in which vasa seems to be produced
in vasa . These results suggest a requirement for vasa
at two distinct phases of oogenesis. Early during
oogenesis vasa is necessary for the development of the
oocyte and nurse cells following their formation,
whereas in the second half of oogenesis vasa is required
for the localization of cytoplasmic determinants
required for germ line formation and abdomen specifi-
cation. During embryogenesis, there may be additional
requirements for vasa. At the stage of the somatic
blastoderm formation, vasaPD and vasaDL embryos
show frequent cellularization defects (data not shown).
This may reflect an essential function of the low level of
vasa seen throughout the wildtype embryo, as revealed
in immunocytochemical experiments.
The vasa protein has a high degree of homology with
members of the helicase class of RNA-binding proteins
(Hay et al. 1988; Lasko and Ashburner, 1988), sugges-
ting that it functions in some context as an RNA-
binding protein. Three possible roles that vasa as an
RNA-binding protein might be playing in the function
of the posterior determinant system are (1) to regulate
the translation of localized transcripts required for
determination of posterior structures; (2) to participate
in the localization of the posterior determinants by
providing a permissive environment for this localization
(its helicase activity stabilizing a particular transcript
conformation that allows binding by specific RNA-
binding proteins) or (3) to localize the determinants
directly. The last possibility is unlikely in light of the
vasa localization phenotype in Bicaudal-D embryos:
females /ransheterozygous for vasa and Bicaudal-D
suppress the bicaudal phenotype (anterior function of
abdominal determinants) though vasa is not localized
anteriorly in Bicaudal-D embryos. We cannot com-
pletely rule out the possibility that vasa is required for
directly targeting determinants to the posterior pole in
the normal embryo, but that it plays a different role in
localization via a Bicaudal-D-dependent mechanism.
The first two possibilities can be distinguished on the
basis of the localization of the nanos product in Bi-
caudal-D vasa transheterozygote embryos. Since em-
bryos from heterozygous vasa females, which contain
large amounts of vasa localized to the posterior pole,
give rise to normal posterior structures while the
anterior formation of abdominal structures is sup-
pressed in /raAwheterozygotes of vasa and Bicaudal-D,
it is possible that the vasa protein present throughout
the somatic region of the cleavage stage embryo pro-
vides the vasa-dependent activity present in Bicaudal-D
embryos. Decreasing the level of vasa in fransheterozy-
gotes reduces the amount of available anterior vasa
below a critical threshold and thus prevents anterior
abdomen formation.
Localization of vasa
Following fertilization or egg activation polar granules
undergo rapid changes in their associations with other
structures and in their morphology. During oogenesis
polar granules are associated with mitochondria and
appear to contain large amounts of RNA. Following
either egg activation or fertilization, they lose this
association with mitochondria, fragment and become
associated with polysomes (Mahowald, 1962, 1968,
1971b). These observations raise the possibility that
different mediators of localization, including perhaps
cytoskeletal elements, may be used during oogenesis
and early embryogenesis.
The process of vasa localization is altered at an early
stage by oskar and staufen mutations. Females homo-
zygous for strong alleles of staufen and oskar synthesize
roughly normal amounts of vasa though it does not
become localized during oogenesis. Thus both oskar
and staufen gene products are required for some aspect
of the initial vasa localization event. Further evidence
for this hypothesis derives from studies of oskar301, the
temperature-sensitive allele. The temperature-sensitive
period for the os/car-dependent development of the
abdominal deletion phenotype corresponds to the last
half of oogenesis (stages 10-14), the same time period
during which polar granules become localized to the
posterior oocyte pole (Lehmann and Niisslein-Volhard,
1986). Indeed, some vasa is localized at permissive, but
not at nonpermissive, temperatures during oogenesis.
Thus the strength of the oskar phenotype is related to
the amount of vasa, and probably polar granules, that
become localized to the posterior pole. The oskar
activity in oskar301 mutants is not normal even at the
permissive temperature since pole cells do not form in
these embryos and the vasa that is localized to the
posterior pole during oogenesis does not remain local-
ized following oviposition. The latter observation
suggests that oskar-dependent activity (which may be
either quantitatively or qualitatively insufficient in the
mutant) is also required during cleavage stages of
embryogenesis to maintain vasa localization.
Though mutations of oskar, staufen, cappuccino and
spire have a similar vasa localization phenotype (this
paper; Manseau and Schiipbach, 1989) they differ in
their interactions with Bicaudal-D. Bicaudal-D in a
homozygous oskar background suppresses the bicaudal
phenotype (Lehmann and Nusslein-Volhard, 1986),
while Bicaudal-D in a heterozygous staufen background
(Mohler and Wieschaus, 1986) or a homozygous cap-
puccino or spire background (Manseau and Schiipbach,
1989) results in an enhancement of the bicaudal pheno-
type.
If the product of the oskar locus is a polar granule
component having a similar distribution to that of vasa
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and this product is required for some aspect of abdomi-
nal determinant (nanos) function, the block in anterior
function of the abdominal determinants could be simi-
larly explained. Oskar product function may be
required for nanos function either indirectly, through
interactions with vasa, or directly through association
with the products of the nanos or Bicaudal-D loci. In
the case of staufen, cappuccino and spire, a likely
possibility is that these gene functions are required for
transport of the abdomen-specifying signal (nanos) to
the posterior pole. In the absence of any of these gene
functions, posterior localization of the abdomen-in-
ducing signal does not occur. In Bicaudal-D embryos,
some of this activity becomes localized to the anterior
pole under the influence of the Bicaudal-D-dependent
localization mechanism. In the double mutant combi-
nations of Bicaudal-D with staufen, cappuccino or spire
described above, more of this activity becomes local-
ized to the anterior pole because the action of the
Bicaudal-D-dependent localization mechanism is not
competing as much or at all (for nanos-bind'mg perhaps)
with elements required for normal posterior-dependent
localization.
The phenotype of tudor is more difficult to interpret,
since tudor , a strong allele of tudor, is almost
certainly hypomorphic. Boswell and Mahowald (1985)
have shown in a series of tudor mutants that the number
and size of structures tentatively identified as polar
granules, based on their electron-dense appearance and
association with mitochondria, decreases as the severity
of the abdominal deletion phenotype increases. Polar
granules are not apparent in fudorWC8/Df(2L)PL3
heterozygotes (Boswell and Mahowald, 1985), yet we
see good vasa localization during oogenesis and during
early cleavage stages following fertilization. On the
other hand, consistent with this phenotypic series, we
find that in tudor2, a weaker tudor allele, the localized
vasa immunoreactivity typically is more abundant than
in mdorWC8/Df(2L)PL3 heterozygotes. It is not clear
from this phenotypic series, however, whether vasa
would be localized in oocytes from mothers totally
deficient in tudor function. One possibility is that the
strong phenotype (if viable) is a complete lack of
localization. Alternatively, or perhaps in addition to
this aspect of tudor function, tudor may play some other
role in polar granule function following fertilization.
This seems likely because, though vasa localization is
quite good in early cleavage stage tudor embryos, and
vasa immunoreactivity remains somewhat localized un-
til about the time the pole cells would normally be
forming, pole cells do not form and abdominal segmen-
tation is disrupted to a variable extent. The fact that
vasa is well localized in oocytes and early embryos from
fudorwcs/Df(2L) PL3 females, but that localized polar
granules are not visible with electron microscopy
suggests that the tudor product is a polar granule
component required for interactions between granule
components necessary for assembly of a functional
granule structure. The observation that frarc^heterozy-
gotes of tudor and Bicaudal-D suppress the bicaudal
phenotype, as is the case with vasa, is also consistent
with the idea that tudor encodes a polar granule
component required for the function of the posterior
determinants. The observation that the abdominal
segment deletion phenotype is variable in tudor*'09',
whereas pole cells never form, may simply reflect a
higher threshold requirement for fwrfor-dependent
functions for pole cell formation, or it may indicate a
qualitative difference in the mutant's ability to carry out
functions required for abdomen and pole cell develop-
ment.
valoisPE appears to be a strong allele of valois, based
on the consistency of both the abdominal deletion and
vasa localization phenotypes, either as a homozygote or
in heterozygous combination with a deficiency for the
region. It shows good localization during oogenesis, but
this disappears very rapidly following fertilization, even
though normal amounts of vasa protein can be detected
on Western blots. This sugests that the maternal valois
product is required for some aspect of stabilization of
vasa localization following fertilization. Interestingly,
many valois embryos do not cellularize, or cellularize
incompletely. This phenotype is consistent with the
possibility that valois might be important for some
aspects of cellular function (the cytoskeleton perhaps)
in the embryo which are required for both somatic
cellularization and maintenance of polar granule local-
ization. We cannot completely rule out a role for valois
during the initial localization process.
Summary
In summary, it seems likely that, based on vasa's
homology with RNA helicases, its localization pheno-
type in Bicaudal-D and its suppression of the bicaudal
phenotype, a primary role of vasa in the function of the
posterior determinant system is to regulate the trans-
lation of mRNA important for determination of pos-
terior structures and/or to provide a permissive en-
vironment (RNA secondary structure) for RNA
localization via other RNA-binding proteins. The fact
that localized polar granules are absent in vasa mutants
indicates that vasa is also a necessary component of the
granules. Vasa's role during early oogenesis is myster-
ious.
The vasa localization phenotypes described for the
other six posterior group genes show that function of
these genes is required for posterior vasa localization
during oogenesis (oskar, staufen, cappuccino and
spire), its maintenance following fertilization (valois),
or events occurring after fertilization required for
macroscopic polar granule structure and posterior
determinant functions (tudor). Mutations in staufen,
cappuccino, spire and oskar all affect early steps of vasa
localization in oocytes. Their different interactions with
Bicaudal-D, however, suggest that staufen, cappuccino
and spire gene functions are likely to be required for
transport of determinants to the posterior pole or their
localization there, while oskar activity, perhaps in the
form of another polar granule component or a molecule
required for posterior-specific localization of the gran-
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ules, is required for proper function of the determi-
nants. In addition, oska r-dep&ndent activity may also
be required for maintenance of posterior vasa localiz-
ation following fertilization. The observation that valois
mutations affect somatic cellularization and the main-
tenance of vasa localization following fertilization
suggest that the valois product functions as a cytoskel-
etal component required throughout the embryo fol-
lowing fertilization. In contrast, tudor function may not
be required for vasa localization during oogenesis or the
maintenance of this localization following fertilization
since vasa remains localized through late cleavage
stages of embryogenesis in tudor embryos. This obser-
vation and the lack of macroscopic polar granules seen
in tudor embryos suggest that the tudor product is a
polar granule component that is required for the
assembly of that structure. Since tudor embryos have
abdominal segment deletions and lack pole cells though
vasa is localized relatively normally, and tudor sup-
presses Bicaudal-D, tudor may be required for the
activation of the posterior determinant activity or to
provide an environment permissive for the localization
of this activity.
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